Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor

Author:

Robinson Giles W.1,Kaste Sue C.2,Chemaitilly Wassim3,Bowers Daniel C.4,Laughton Stephen5,Smith Amy6,Gottardo Nicholas G.7,Partap Sonia8,Bendel Anne9,Wright Karen D.10,Orr Brent A.11,Warner William C.12,Onar-Thomas Arzu13,Gajjar Amar1

Affiliation:

1. Department of Oncology, Division of Neuro-Oncology, St. Jude Children’s Research Hospital, Memphis, TN, USA

2. Department of Radiological Sciences, Division of Diagnostic Imaging, St. Jude Children’s Research Hospital, Memphis, TN, USA

3. Department of Pediatric Medicine, Division of Endocrinology, St. Jude Children’s Research Hospital, Memphis, TN, USA

4. Division of Pediatric Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA

5. Starship Blood and Cancer Centre, Starship Children’s Hospital, Auckland, NZ, USA

6. Division of Pediatric Hematology/Oncology, The Haley Center for Children’s Cancer and Blood Disorders at Arnold Palmer Hospital, Orlando, FL, USA

7. Department of Haematology and Oncology, Princess Margaret Hospital for Children, School of Paediatrics and Child Health, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia

8. Department of Neurology, Division of Child Neurology, Lucile Packard Children’s Hospital at Stanford, Stanford University, Palo Alto, CA, USA

9. Cancer and Blood Disorders Program, Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN, USA

10. Pediatric Medical Neuro-Oncology, Dana-Farber Boston Children’s Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA

11. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, TN, USA

12. Department of Orthopedic Surgery, Campbell Clinic, University of Tennessee College of Medicine, Germantown, TN, USA

13. Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN, USA

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3